CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 4 Open-market sale Chief Financial Officer sold 1,648 shares at $6.00 ($9,888)
- 4 Open-market sale Chief Executive Officer sold 3,295 shares at $6.00 ($19,770)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 6,705 shares at $6.05 ($40,565)
- 4 Open-market sale Chief Financial Officer sold 3,352 shares at $6.05 ($20,280)
- 4 Option exercise Director acquired 37,500 shares (option exercise)
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 1,000 shares at $7.35 ($7,350)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $7.16 ($71,600)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at $7.30 ($146,000)
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- 4 Shares withheld for taxes Chief Executive Officer gave up 22,387 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 9,277 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 7,747 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,187 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,102 shares (to pay taxes)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
Page 21 of 41 · 802 filings